Virtus LifeSci Biotech Cl... (BBC)

NYSEArca: BBC · 실시간 가격 · USD

53.81

+0.55 (1.03%)

종가 기준: Aug 18, 2026, 3:59 PM

1.03% (1D)

매수호가	n/a
시가총액	n/a
매출 (ttm)	n/a
순이익 (ttm)	n/a
베타	n/a
EPS (ttm)	n/a
P/E (ttm)	n/a
선행 P/E	n/a
P/B (ttm)	n/a
P/S (ttm)	n/a
Earnings Date	n/a

매도호가	83.97
거래량	6,708
평균 거래량 (20일)	22,956
시가	53.47
전일 종가	53.26
일중 범위	53.18 - 53.81
52주 범위	21.83 - 54.95
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

BBC 소개

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval....

[더 보기]

산업 n/a

섹터 n/a

IPO 일자 Dec 17, 2014

직원 수 n/a

상장 거래소 NYSEArca

티커 BBC

전체 기업 정보

재무 실적

undefined년 Virtus LifeSci Biotech Clinical Trials ETF의 매출은 n/a로, 전년 n/a 대비 undefined% 증가했습니다. 순이익은 n/a로, undefined% 증가했습니다.

재무제표

뉴스

3주 전 · MarketBeat

Innovative ETF Strategies That Are Paying Off This Summer

Amid record ETF inflows, niche funds like BBC, LATR, and FMED offer targeted exposure to biotech trials, buy-now-pay-later firms, and disruptive medicine, with notable recent returns.